Significant rise of the prevalence and clinical features of childhood asthma in Qingdao China: cluster sampling investigation of 10,082 children

Our study was conducted in Qingdao, a beautiful coastal city in eastern China with a temperate monsoon climate. Cluster sampling survey method was used. The required sample size, calculated with prevalence of 1.54% in 2000, included approximately 10,000 subjects. We randomly selected nine schools, seven kindergartens, and three communities in Qingdao to be investigated using the lottery method. Our subjects were the children born between July 1, 1996 and June 30, 2010, which had a total of 10,800 children.

Investigators were doctors or medical students, who were trained before the program. ISAAC and National Epidemiology Study of Asthma and Allergies in China questionnaires were applied in the survey. Two rounds of surveys were launched. First, all the respondents completed the screening questionnaire (ISAAC questionnaire), in which patients suspected of asthma were selected. Second, after the diagnosis by pediatricians in our hospital, asthma patients were asked to complete a second in-depth questionnaire for asthma. A control group that matched the patients was formed to complete a second in-depth questionnaire for non-asthma (National Epidemiology Study of Asthma and Allergies in China questionnaire). In the case of young children, the questionnaires were completed by students or their parents. All the papers were checked by investigators before adoption. The survey started in September 2010 and finished in March 2011.

The following diagnostic criteria of asthma were used: (1) respondents had been diagnosed with asthma by professional pediatricians of three A-grade hospitals and received asthma treatment, or (2) respondents were diagnosed in our hospital using the diagnostic criteria of GINA 2012 [6].

The investigation was performed in accordance with the Declaration of Helsinki and approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University. Each questionnaire was approved by the child’s guardian.

The prevalence of childhood asthma in Qingdao was 3.69%. Overall, 10,082 children were investigated. Among these children, 373 were diagnosed with asthma. From this group of children, 57 were identified to have cough variant asthma, which accounted for 15.3%. The prevalence in children aged 3–7 was higher than the average. Table 1 shows the prevalence of asthma in different ages.

Based on first asthmatic attack, the children were divided into three age groups: <3 y, 4–6 y, and 7–14 y. The incidents of first attack were 79.3%, 17.7%, and 3%, respectively. Based on the same grouping, 39.2%, 56.5%, and 4.3% of the children of each group were initially diagnosed as asthmatic.

Asthma attacks in 71.2% of the asthmatic children were caused by respiratory tract infection. Other precursors included cold air, exercise, eating fish, and smoke, which accounted for 42.2%, 28.2%, 13.7%, and 9.4%, respectively.

Runny nose, sneezing, and nasal congestion were identified as the most common signs of asthma attack (63.4%, 62.9%, and 53.0%, respectively). Table 2 presents the details. In all clinical manifestations, cough was observed on 95.7% of the patients and 35.8% of the asthmatic children had cough for more than one month. Other manifestations were wheezing (82.3%) and suffocation (41.4%). Table 3 shows every clinical manifestation and its incidence. Most asthmatic children (72.3%) felt that the asthma attack was tolerable, but 17.5% had to visit the emergency room because of severe asthma attacks.

Figure 1 shows the high use of quick-relief medications, such as bronchodilators (87.4%), and low use of preventative medication, such as ICS (46%). Among the patients, 72.6% and 69.9% used anti-allergy medicine and leukotriene modifiers, respectively. Traditional Chinese medicine was used by 6.5% of the patients. Immunomodulators, theophylline, and desensitization therapy were rarely used. In an acute attack, 29.8% patients took antibiotics and 10.5% were given systemic application of steroid.

This disease entailed significant costs for a number of asthmatic children and their families; 71.8% of the parents spent Ұ2000–5000 (approximately $ 300–750) annually for their asthmatic children; 14.2% spent less than ⊠2000, and 14% spent more than Ұ5000. Nevertheless, almost all parents (99.7%) expressed their capability to afford the treatments.

After 2000, results of several studies on the prevalence of childhood asthma showed no changes [7‐9] or even significant decreases [10, 11]. By contrast, more studies indicated an increase in the prevalence [12‐16]. Our study agrees with the latter. The prevalence of childhood asthma in Qingdao (3.69%) was considerably higher compared with the data gathered in 2000 (2.67%) [5], The trend that was also observed in other Chinese cities [17]. The prevalence of childhood asthma in Qingdao was higher than the national average (3.02%) [18].

Environmental, climate, and industrial factors may be related to the high prevalence of childhood asthma in Qingdao. First, the moist air in Qingdao, a beach city, provides a good environment for dust mites and mildew, which may be the most important allergens of asthma [19]. Second, Qingdao residents are partial to seafoods, which easily cause allergic disease. Third, the farming environment, which offered protective effect on the development of asthma in children [20], has been affected by the rapid industrialization, which also increased air pollution. The environmental and climate factors definitely contribute to the causes of asthma [21, 22]. LIU Yan-li reported that mites were the major allergens, and eating seafoods was an important risk factor for asthmatic children in Qingdao [23]. Additionally, many patients informed us that they felt much better in another city. However, the aforementioned potential reasons require further study. We are working hard to complete such study.

In recent years, an increasing number of Chinese doctors have become familiar with GINA, which resulted in significant improvement in the diagnosis of asthma. In the survey, 97% of asthmatic children had their first attack at <6 y. Meanwhile, 95.7% were initially diagnosed with Asthma at <6 y. Most (98.7%) asthmatic children can be inferred to have received accurate diagnosis at the initial period of the disease.

Among the asthmatic children, 71.2% had suffered asthma attack after contracting respiratory tract infection. Clearly, the infection of the respiratory tract had a close relationship with asthma. The possible mechanism was that the pathogen injury of the airway epithelial, which caused the airway to become hyper responsive and induced asthma to occur more easily. Dr. Gern reported that respiratory syncytial virus and rhinovirus were the main viruses causing asthma attacks in infants and older children, respectively [24]. Atypical microorganisms were also reported to influence the occurrence of an asthma attack [25]. Therefore, asthmatic children should be protected from respiratory infection to reduce the risk of asthma attack.

Epidemiological data indicated that asthma control was suboptimal in both developed and developing countries [26‐28]. The same problem was also found in our survey. We found that only 46% of asthmatic children in Qingdao China used ICS, which was the main and basic control medicine for asthma [6]. However, this percentage denotes considerable progress compared with data from 2000, in which only 19.6% of asthmatic children used ICS [5]. Compared with the use of bronchodilators (87.4%), anti-allergy (72.6%), and leukotriene modifiers (69.9%), the resistance to the use of ICS was stronger, which may have come from parents. The possibility of steroid-related side effects could be the first reason. Numerous parents refused immediately when medicine with steroid was discussed. Other parents put forward the concern on whether ICS would result in a short or unhealthy child. Lack of apparent efficacy may be the second reason. Many parents complained over the uselessness of ICS as proven by the lack of immediate change in the condition of their children. Moreover, bronchodilators quickly transformed the frowns on children’s faces to smiles. Based on following observations, we believe economic factors did not play a critical role in the parents’ medicine choice. As mentioned earlier, almost all parents expressed their capability to afford the treatments. Moreover, the daily cost of leukotriene modifiers was not lower than that of ICS in China. GINA has proven that ICS is the best medicine for asthma control. A series of research demonstrated that ICS produced minimal side effects [6]. Many parents were worried over the height of their children. In early 2000, the New England Journal of Medicine revealed that inhaling medium or low dose ICS did not affect the height of asthmatic children [29]. Nevertheless, guiding parents and their children toward acceptance of this idea remains a difficult task to accomplish.